rfxcel Awarded ISO 9001:2015 Certification

14 Aug 2019

rfxcel, the leader in track and trace solutions for global supply chains announced that it is now ISO 9001:2015 certified for Quality Management Systems.

The certifying organization used by rfxcel examined rfxcel’s commitment to customer service and requests, commitment to quality from upper management, and processes and procedures put in place to ensure the delivery of quality systems. rfxcel demonstrated its long-standing commitment to quality management and processes and was officially certified on November 4, 2018.

rfxcel Awarded ISO 9001:2015 Certification

“This certification is a testament to rfxcel’s determination and commitment to continually improve as a business, provide our customers with uncompromising experiences, and drive a culture that produces high-quality products and services. Attaining this certification indicates the dedication rfxcel has taken in supporting our customers and exceeding their expectations. Quality is one of our strengths, and it is the reason we are the preferred partner for organizations globally.” – Amit Sewak, rfxcel, Director of Quality Management & Validation.

The scope of the certification included rfxcel’s flagship product rfxcel Traceability System for serialization (rTS). rTS is used by some of the world’s largest pharmaceutical manufacturers, wholesalers, distributors, and dispensers and is being adopted in other industries like Food and Beverage, Consumer Goods, and the Public Sector.

According to ISO, the 9001:2015 certification means that rfxcel demonstrated the seven following quality management principles for rTS:

• QMP 1 Customer Focus
• QMP 2 Leadership
• QMP 3 Engagement of People
• QMP 4 Process Approach
• QMP 5 Continual Improvement
• QMP 6 Evidence-Based Decision Making
• QMP 7 Relationship Management

“Very few if any of our competitors can claim to be ISO 9001:2015 certified. It is a testament to our role as a leader in our industry and our commitment to quality. This certification assures our customers that quality management practices are baked into our systems. Those quality practices and procedures are passed on to our customers through consistent products and services, which brings business benefits like a lower total cost of ownership and predictable outcomes.” – rfxcel, CEO Glenn Abood

Read More

Companies mentioned

Related tags

Research & Development

Related news

Ajinomoto introduces fast track platform for drug product manufacturing

Ajinomoto introduces fast track platform for drug product manufacturing

30 Jun 2020

AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.

Read more 
Piramal acquires solid oral dosage drug product facility from G&W Laboratories

Piramal acquires solid oral dosage drug product facility from G&W Laboratories

22 Jun 2020

The site can also produce liquids, creams, and ointments, further expanding the CDMO's portfolio.

Read more 
Catalent and ViralClear Pharmaceuticals partner on potential COVID-19 treatment

Catalent and ViralClear Pharmaceuticals partner on potential COVID-19 treatment

22 Jun 2020

The CDMO will work on developing a solution and a solid oral dosage form of ViralClear's merimepodib.

Read more 
Sanofi to build EUR 490 million vaccine production facility in France

Sanofi to build EUR 490 million vaccine production facility in France

16 Jun 2020

The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines

Read more 
Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's

Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's

8 Jun 2020

Optimizing the dosage form's efficiency reduces the amount of drug required in each patch.

Read more 
Emergent bags $628 million landmark CDMO deal to produce COVID-19 vaccine candidates

Emergent bags $628 million "landmark" CDMO deal to produce COVID-19 vaccine candidates

2 Jun 2020

The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs.

Read more 
Changes needed to prevent controversial pay-for-delay pharma deals

Changes needed to prevent controversial pay-for-delay pharma deals

26 May 2020

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Read more 
SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

26 May 2020

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Read more 
AbCellera and Lilly seal multi-year antibody discovery collaboration

AbCellera and Lilly seal multi-year antibody discovery collaboration

25 May 2020

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

Read more 
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

25 May 2020

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

Read more